Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-08-27 00:00:00 ET · period of report 2025-08-25 · accession 0001804567-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-27 | 2025-08-25 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $12.98 | +14.0K | 29.5K | +90% | +$181.7K |
| D | 2025-08-27 | 2025-08-25 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | S - Sale+OE | $44.51 | -14.0K | 15.5K | -47% | -$623.1K |
| D | 2025-08-27 | 2025-08-25 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | -14.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-25 | M | A | 14,000 | $12.98 | 29,496 | D | — | — | (F1) Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-08-25 | S | D | 14,000 | $44.51 | 15,496 | D | — | — | (F2) The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 1, 2026. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2025-08-25 | M | D | 14,000 | $0.00 | 0 | D | $12.98 · — to 2026-03-01 | 14,000 Common Stock | (F3) The option vests in four equal annual installments beginning on March 1, 2017. |